Recent advances in nanomaterials for colorimetric cancer detection

Haixia Wang,Tingting Wu,Mingqiang Li,Yu Tao
DOI: https://doi.org/10.1039/d0tb02163f
IF: 7.571
2021-01-01
Journal of Materials Chemistry B
Abstract:Colorimetric cancer detection based on nanomaterials is comprehensively overviewed including the sensing principles, targeted biomarkers, emerging nanomaterials and advanced strategies.
materials science, biomaterials
What problem does this paper attempt to address?
The paper aims to address the issue of early cancer diagnosis. Specifically, the authors focus on how to develop simple, cost-effective, and highly sensitive colorimetric methods (color change methods) using nanomaterials to detect cancer biomarkers. Traditional cancer diagnostic methods, such as biopsies, cancer imaging, mass spectrometry-based proteomics, and fluorescence spectroscopy-based detection, although effective, often require expensive equipment and complex operational procedures. This limits their application in routine check-ups, causing many patients to miss the optimal time for early cancer detection and treatment. Therefore, developing simple and economical cancer diagnostic technologies is crucial for improving early cancer diagnosis rates. In the paper, the authors review the recent developments in colorimetric cancer detection technologies based on nanomaterials and discuss strategies to improve detection sensitivity and selectivity. They detail the basic principles of colorimetric detection, including color changes based on plasmonic nanoparticles, color changes based on the catalytic action of nanozyme materials, and other color change behaviors induced by target composition or conformational changes. Additionally, the article lists emerging nanomaterials used for cancer-related detection and categorically discusses their roles in enhancing the performance of colorimetric cancer detection. In summary, the paper attempts to provide a comprehensive overview of the latest research progress in nanomaterial-based colorimetric cancer detection technologies, exploring their potential in clinical applications and the challenges they face.